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The world economy has become one global marketplace and more and more companies decide to expand their operations internationally, including the com-missioner of this thesis. In order to comply with confidentiality obligations, the commissioner was called Company X and confidential material has been re-moved from the public report.   Company X is a Finnish IT start-up that provides a customizable mobile device service. Since the commissioner plans to enter the healthcare market in Ger-many, the objective of this thesis was to determine how the start-up could enter this new market successfully. To make the results as targeted as possible, the study concentrated on the hospital market. Data was collected from books, arti-cles, reports, and digital sources, which were enriched by personal interviews with medical professionals and experts in the German hospital sector.   Results of the research showed that the hospital sector is a large and complex part of the German healthcare system, that it is influenced by health insurance companies and the state, and that prevailing trends are the lack of qualified per-sonnel, cost and efficiency pressure, and digitalization. In international compari-sons, the German hospitals are still falling behind, especially the small, regional hospitals. The installation of new IT solutions is usually triggered by new legisla-tions or the IT department and the final decision lays with the business manage-ment which is responsible for the hospital finances. For end-users such as nurses and doctors, it is crucial that new systems, devices, or applications support the clinical processes. Many companies are already providing hospitals in Germany with systems, software, digital devices, and applications that can be integrated into the existing infrastructure to improve processes. Distributors are not yet widely specialized in combinations of mobile devices and software, but many young IT companies are open to partnerships that could add value to their product portfolio.  The findings indicated that the commissioner should attend different events in Germany to meet potential customers, distributors, and partners. The service should first be introduced in pilot projects in small hospitals, and thereby it could be beneficial to partner with a company that already has a trusted reputation in the market. The main contact persons in German hospitals at an initial stage are the potential end-users of the solution, such as nurses.  
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ABBREVIATIONS AND TERMS 
 
 
CEO Chief Executive Officer 
CIO Chief Information Officer 
COVID-19 Corona Virus Disease 2019 
DVG Digitale-Versorgungs-Gesetz  
(Act to Improve Healthcare Provision through Digitaliza-
tion and Innovation) 
eGK Elektronische Gesundheitskarte (electronic health card) 
EMRAM Electronic Medical Adoption Model 
EPR Electronic Patient Record 
GDP Gross Domestic Product 
HIS Hospital Information System 
ICT Information and Communications Technology 
IT Information Technology 
TI Telematics Infrastructure 
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1 INTRODUCTION 
 
 
1.1 Research background 
 
The world economy has shifted away from domestic markets towards one global 
marketplace where not only goods, resources, and services but also culture, 
ideas, and beliefs are being exchanged. The international marketplace enables 
businesses to reach new customers more rapidly and efficiently and offers seem-
ingly endless opportunities for business growth. It is therefore not surprising that 
more and more companies are deciding to go global with their activities, although 
not all companies are following the same objectives. The most common reasons 
for companies to internationalize are access to new markets, access to local tal-
ents, business expansion and growth, gaining competitive advantages, and es-
tablishing regional centers. (Sinead 2019.)  
 
The thesis commissioner Company X is a Finnish startup that provides customi-
zable mobile device services that can be used by different user groups, such as 
doctors, nurses, and patients. These services are already used in more than 400 
organizations around the world. As a next step in its internationalization process, 
the company aims to enter the German healthcare market. By increasing its in-
ternational involvement, Company X pursues the objective of building a new cus-
tomer base in Germany, improving business growth, and staying ahead of the 
competition.  
 
Having a thorough understanding of the target market is key for successful mar-
ket entry and since the German healthcare market is particularly large and com-
plex, an in-depth research is inevitable to gain this understanding. Also, it will be 
necessary to focus on one part of the market at a time and proceed with the 
penetration step by step.  
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1.2 Research objective and research questions 
 
The objective of this thesis is to provide the commissioning company with an in-
depth understanding of the factors shaping the German healthcare market in or-
der to assess what kind of efforts will have to be undertaken to successfully ex-
pand its operations to the new target market. The intended outcome is to deliver 
a starting point from where Company X can take the first step in entering the 
German healthcare market. 
 
To make the results as targeted as possible, the thesis will concentrate on the 
hospital market and provide a general overview of the healthcare system in Ger-
many and its current situation. Yet, the results will also provide an outlook on 
other aspects of the German healthcare market for future research.  
 
By analyzing the target country, the commissioner will gain a comprehensive 
overview of the current environment and trends in Germany and understand how 
the external factors could impact the business. An investigation of the German 
healthcare system and the hospital market, supported by expert interviews, will 
serve the purpose of understanding the legal bases, internal processes, and chal-
lenges of potential customers. This includes that the degree of digitization in Ger-
man hospitals will be analyzed and the decision-makers in the hospitals will be 
identified. Thus, the outcomes will help the commissioning company prepare to 
meet the requirements and expectations in the German hospital market. A com-
petitive analysis will reveal the strengths and weaknesses of the existing compet-
itors and thereby indicate where the commissioning company itself stands and 
how it can differentiate from the competition. Further, potential distributors and 
partners will be identified and analyzed. The results will enable the commissioner 
to set up a concrete market entry strategy and take the first steps in introducing 
their service to the new customers. 
 
The ultimate stage in the thesis process will be the development of a comprehen-
sive market entry approach that can be applied to other markets and countries if 
the commissioner decides to internationalize further in the future. 
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Based on the desired outcome of this study, the main research question is: 
 
• How can a Finnish IT start-up successfully enter the German hospital market? 
 
 
The following sub-questions have been formulated to support the main question: 
 
• What are the characteristics of the German hospital market? 
• Who are the potential customers and what are their needs and expectations? 
• Who are the competitors and what are their strengths and weaknesses? 
• How to introduce the service to the new target market?  
 
 
1.3 Research methodology 
 
 
1.3.1 Data collection 
 
The success of market research underlies the collection of relevant and high-
quality data which can only be achieved using effective data collection methods. 
Data can be collected from both primary and secondary research sources. Pri-
mary data is original data that is collected first-hand by the researcher, for exam-
ple in interviews or questionnaires, while secondary data derive from already pub-
lished information such as books, articles, statistics, or web pages.  
 
Research can be further divided into qualitative and quantitative research. The 
qualitative research approach focuses on understanding ideas, motivations and 
opinions, and qualitative data is mainly collected in interviews, focus groups, and 
observations. Quantitative data, on the other hand, can be collected by surveys, 
questionnaires, or observations that produce numerical data that can be used to 
test hypotheses and formulate facts. (Blythe 2012, 100-104.) 
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This study started with the collection of secondary data from books, articles, and 
internet sources in order to obtain solid background information about the exter-
nal factors and trends that are influencing the German country, its healthcare 
system, hospital landscape, customers, and competition. This information was 
then used to design primary research to receive more specific results. The pri-
mary research was conducted in personal expert interviews with German medical 
staff and industry experts. These interviews aimed to gain insights into the daily 
routines and challenges of medical and managerial staff. Thereby it was possible 
to get a deeper understanding of the market dynamics, needs and wants of the 
hospitals, and the decision-making processes regarding IT (information technol-
ogy) investments in German hospitals.  
 
 
1.3.2 Data analysis 
 
The qualitative data were analyzed by comparing findings from secondary 
sources with the information obtained in the expert interviews. Further, a SWOT 
analysis, Porter’s Five Forces, the Marketing Mix, and the Foreign Distributor 
Evaluation System were used to analyze and summarize all the data collected 
during the research process to demonstrate the complex interaction of different 
factors and key players in the German healthcare market.  
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2 THEORETICAL FRAMEWORK 
 
 
2.1 Marketing Mix 
 
The marketing mix is a strategic toolbox that helps companies create the right 
marketing strategy that will guide every business decision. The marketing mix 
includes the product or service itself, its price, promotion, and the place where 
the product or service is sold. The product can be both tangible and intangible 
and is usually characterized by its functions, physical features such as design 
and packaging, and related services. The price is the value that customers need 
to exchange to receive the product and determines the profits that a company will 
get. Place refers to where customers look for the product and how the company 
distributes the products or services. Promotion includes all activities that are 
meant to communicate with customers and inform them about the products or 
services. (Solomon, Marshall & Stuart 2006, 28-30).  
 
If a company plans to expand internationally, it must be decided to what extend 
the marketing mix has to be adapted to the local settings in the new countries. A 
distinction is made between standardization and localization strategy. Choosing 
a standardization strategy means entering a new market with the same marketing 
mix as used in the home market. On the other hand, implementing a localization 
strategy means adapting the product, price, promotion, and distribution to the 
new market. While some marketers argue that due to advances in globalization, 
the needs and wants of customers from different countries have become similar, 
others hold to the idea that each culture is unique, and therefore, companies 
should tailor their strategies to local environments. Regarding the product, com-
panies have the choice between selling the same product in the new market, 
modifying it, or creating an entirely new product. Similarly, it has to be evaluated 
whether the same promotional message will appeal to customers in different 
countries or whether the product promotions need to be customized. A far more 
difficult decision is pricing, particularly for international markets. Customers in dif-
ferent countries may have different price perceptions, and at the same time, of-
fering products to international customer groups involves higher costs for the 
company.  When selling to foreign countries, companies need to take into account 
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that extra costs such as transportation costs, tariffs, and currency exchange rates 
will occur. Moreover, if the products will be sold via distributors or sales partners, 
they will take their shares from the profits. Establishing a reliable and effective 
distribution network is particularly important if the company itself does not plan to 
open subsidiaries in the new market. (Solomon et al. 2006, 94-96.) 
 
In addition to the so-called 4 P’s of the marketing mix, Lauterborn (1990, 26) 
suggests that companies should not solely focus on the product, but rather on 
the wants and needs of the consumers, the cost to satisfy, the convenience to 
buy and the communication. Instead of simply producing as much as possible, 
companies should study the wants and needs of their customers and ensure that 
they only sell products that are wanted. Further, Lauterborn wants companies to 
consider that the price is only a minor part of the overall cost that customers are 
paying to acquire the product. For example, the cost to satisfy can include the 
time spent to get the product, the conscience during its consumption, or its im-
plementation. Thanks to advanced technologies, customers are no longer bound 
to purchase a product from specific locations, but they are able to freely choose 
the most convenient place to buy. Therefore, companies have to think beyond 
traditional distribution channels and focus on creating an excellent buying expe-
rience. Traditionally, promotion has been used as a one-way tool to push prod-
ucts out to customers. Communication on the other hand creates a dialog be-
tween companies and their customers based on their wants and needs. Thus, it 
focuses on the entire buying experience and enables companies to build mean-
ingful customer relationships. (Lauterborn 1990, 26.) 
 
 
2.2 Foreign Distributor Evaluation System 
 
Since small and medium-sized companies often lack the necessary resources to 
export directly to new target markets, it is an attractive option to sell the products 
or services through foreign distributors. Market-based distributors can have im-
portant knowledge and contacts and represent a low-cost way of market entry. 
Yet, exporters find it challenging to find appropriate distributors that act in the best 
interest on behalf of the company.  
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Cavusgil, Yeoh, and Mitri (1995, 300) developed an expert system of 35 evalua-
tion criteria that can help to compare and assess potential foreign distributors. 
The evaluation criteria are divided into five major dimensions: Financial and com-
pany strengths, product factors, marketing skills, commitment, and facilitating fac-
tors (Figure 1).  
 
 
 
FIGURE 1. Criteria for evaluating foreign distributors (Cavusgil et al. 1995, 300, 
modified). 
 
The financial and company strengths dimension aims to analyze the product and 
market expertise of the distributors, their past and present customer relation-
ships, and financial standing. Product factors determine whether the distributors 
are dealing with similar product lines, have the right technical knowledge, and are 
trustworthy to respect intellectual property. The marketing skills dimension in-
cludes the market coverage and established networks, appropriate marketing 
competence to promote the product, and the ability of the distributors to reach 
the target customers. Commitment covers the willingness of the distributors to 
assume responsibilities such as investing in advertising and sales training or 
dropping competing product lines. Finally, the exporter should evaluate the pre-
vious work experience of the distributors with other export companies, their 
knowledge of the local business procedures and regulations, connections with 
influential people, and their personal goals. (Cavusgil et al. 1995, 301-302.) 
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3 GERMANY AS A TARGET MARKET 
 
 
3.1 PESTLE analysis 
 
PESTLE stands for Political, Economic, Social, Technological, Legal, and Eco-
logical and is a tool for analyzing the macro-environmental factors of a specific 
target market of a business. The results of a PESTLE analysis provide a business 
with a deep understanding of the market and is especially useful when starting a 
new business or entering a foreign market. (PESTLE Analysis n.d.) 
 
 
3.1.1 Political  
 
Germany is a federal, parliamentary democratic republic governed under the Ger-
man constitution (“Grundgesetz”). The political powers are divided into executive, 
legislative, and judiciary branches, whereby the judiciary is fully independent and 
the most powerful branch. The head of the state is the Federal President while 
the Chancellor functions as the head of the government. Every four years, the 
German citizens elect a new parliament (“Bundestag”). The country itself is di-
vided into 16 federal states (“Bundesländer”), each of which has its local govern-
ment and state leader in order to protect the local identities and strengthen the 
democracy. (Luyken 2017.) 
 
 
3.1.2 Economic  
 
“With a GDP of $3.86 trillion, Germany is the fourth-largest economy in the world 
and the largest economy in Europe” (Bajpai 2020). The country benefits from 
excellent infrastructure, a highly skilled labor force, and a relatively low unem-
ployment rate of 3,1%. The highest turnover remains to be generated by the au-
tomotive industry, which is also the largest sector of the German economy, fol-
lowed by healthcare and construction. (Make it in Germany n.d.) Germany is the 
second-largest export economy in the world and its biggest export groups are 
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machinery, vehicles, pharmaceuticals, and optical, technical, and medical equip-
ment (Workman 2020). In 2019, 29 German companies were listed in the Global 
500 by the Fortune magazine (2019), with Volkswagen in the top ten and Daimler 
in the top twenty. Given the current situation caused by the epidemic outbreak, 
the German Council of Economic Experts (2020) anticipates that at best, the GDP 
will decline by 2.8% during 2020, at worst by 5.4%. Despite this downturn, the 
experts also estimate that in 2021 the German economy will grow again by 4.9%. 
 
 
3.1.3 Socio-cultural  
 
With more than 82 million inhabitants, Germany has the highest population in the 
European Union. Around 20 million inhabitants come from migratory back-
grounds, making Germany home to a wide range of different cultures, languages, 
and religions. (Make it in Germany n.d.)  
 
Population aging has been a serious issue in Germany over the past years and 
according to the Federal Statistical Office (Statistisches Bundesamt 2019), the 
percentage of people aged 67 or over already surpassed the percentage of peo-
ple under the age of 20 in the year 2010. The number of people aged 67 or over 
will reach at least 21 million people by 2039 and thereby this age group will make 
up 25% of the German population. 
 
Germany’s official language is German, but with a countless number of dialects, 
the pronunciation and vocabulary vary markedly from region to region. Germans 
are generally known for their direct and functional communication style. Espe-
cially in business meetings, Germans do not spend a lot of time on small talk but 
get down to business quickly. (Evason 2015.) 
 
 
3.1.4 Technical  
 
Traditionally, Germany is a country of technology and innovation, and well known 
for its inventions and discoveries. The most remarkable inventions include the 
car, the computer, the jet engine, and x-ray technology (Goethe-Institut n.d.). In 
15 
 
its latest Global Competitiveness Report, the World Economic Forum (2019) 
ranked Germany as the third most innovative economy in Europe. Nonetheless, 
according to the report, the biggest shortcoming of the country is the low level of 
ICT technology adoption. The IMD World Competitiveness Center (2019) comes 
to similar results and ranks Germany 17th in the Digital Competitiveness Ranking 
2019. This low rank indicates that Germany is leaving great potential untapped 
and has to catch up in ICT technology and digitization. More details are provided 
in the Germany Index of Digitization 2019 by Opiela, Tiemann, Gumz, Goldacker, 
Thapa, and Weber (2019): On the one hand, the results of the study show that 
there has been positive overall progress in the digital infrastructure over the past 
years. However, the country is still far from achieving the desired overall coverage 
with fast broadband connections, not to mention fiber-optic connections. Further, 
it can be observed that levels of digitization vary greatly from region to region. 
Berlin is clearly the forerunner, just before the other city-states Hamburg and Bre-
men. They are followed by Saxony, North Rhine-Westphalia, Hesse, Baden-
Württemberg, and Bavaria, which are all economically strong and populous 
states. (Opiela et al. 2019, 36-40.) 
 
 
3.1.5 Legal  
 
The German law is founded based on the constitution and is generally divided 
into private and public law. At the core of the German legal system stands the 
civil law, which contains regulations for everyday civil life, for example for pur-
chase and sale, marriage and divorce, or guardianship. The private law regulates 
the relations between private legal entities, while the public law regulates the re-
lations between private persons and the state. (Plötzsch 2009.) The Federal Con-
stitutional Court (“Bundesverfassungsgericht”) is the highest authority in the Ger-
man legal system and monitors compliance with the constitution. Its decisions are 
unappealable, and all other state bodies are bound by its jurisdiction. (Bundesver-
fassungsgericht 2020.) The federal government has 14 ministries, among them 
the Federal Ministry of Health (“Bundesministerium für Gesundheit”). The main 
focus of the Ministry of Health is health protection, disease control, and biomedi-
cine. Thereby, the work focuses on the preparation of draft laws, ordinances, and 
administrative regulations. (Bundesministerium für Gesundheit 2014.) 
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3.1.6 Environmental  
 
Climate change is an international challenge, and Germany is doing its best to 
contribute to the achievement of the climate protection goals of the United Na-
tions. The German government has enacted an energy reform to protect the cli-
mate and promote renewable energies. Core elements of this reform are wind 
power and electro-mobility, and in the short-term the government aims to shut 
down all nuclear power plants by 2022 and coal-fired power plants by 2038. The 
main objective is to reduce greenhouse emissions by 70% by 2040 compared to 
levels from 1990. (Facts about Germany n.d.) 
 
 
3.2 Healthcare system in Germany 
 
The German healthcare system was established in 1880 and is one of the oldest 
healthcare systems in the world. It is based on the principle of solidarity, meaning 
that all people who are insured receive the same medical care regardless of their 
age, risk of disease, or financial situation. All citizens and permanent residents in 
Germany are obligated to have health insurance, which is provided by both stat-
utory and private health insurance organizations. (Germany HIS n.d.) At the end 
of 2018 more than 73 million people were insured by statutory insurance. Over 
56 million members thereof were paying contributions, while 16 million people 
were co-insured through their family members. (vdek 2020.) 
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FIGURE 2. Distribution of insured persons between statutory and private health 
insurance companies in Germany 
 
Traditionally, the German healthcare system is divided into outpatient care, inpa-
tient care (hospital sector), and rehabilitation facilities. Outpatient care is mainly 
provided by self-employed health care professionals in their private practices. 
The hospital sector is segmented in public, private, and non-profit hospitals that 
provide high-quality medical care to all insured patients throughout the country. 
At the moment, Germany is counting more than 1,900 hospitals, the majority 
thereof private hospitals (720), followed by non-profit hospitals (662). Altogether 
they are equipped with around 500,000 beds and treat over 19 million patients 
annually. Despite the fact that public hospitals account for the smallest number 
of hospitals in Germany, they provide nearly half of all the beds available. There 
are around 40 university hospitals in Germany, both state-owned and privatized. 
(IQWiG n.d.; Deutsche Krankenhausgesellschaft 2018, n.d.) 
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FIGURE 3. Number of hospitals and distribution of beds among them 
 
A total of 5.7 million people, i.e. over 10% of the German workforce, are working 
in the health sector. 1.2 million thereof are employed in hospitals, including 
around 185,000 doctors and 400,000 nurses. (Deutsche Krankenhausgesell-
schaft n.d.) Despite this seemingly large number, German hospitals are con-
fronted with a high lack of qualified staff. Nationwide there are 17,000 unfilled 
vacancies; four out of five hospitals cannot fill vacancies for nursing staff, and 
76% of the nearly 2,000 hospitals struggle to find physicians for open positions 
(Blum, Löffert, Offermanns & Steffen 2019). Statistics of the Federal Labour Of-
fice (Bundesagentur für Arbeit 2019, 8) show that in response to the shortage of 
nurses, more and more foreign nurses are being recruited. In 2018, 40,000 for-
eign nurses were employed in German hospitals, making up 7% of the total nurs-
ing staff. 
 
The public hospitals are financed by both the Federal States and the statutory 
health insurance companies. While the insurance companies are covering treat-
ment costs, the Federal States are investing in the hospital infrastructure and 
procurement of medical equipment. Accordingly, the Federal States decide 
where a hospital is to be built, extended, or closed. (Ortenau Klinikum 2018.) 
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Private hospitals on the other hand do not receive any investment grants or fi-
nancial support from the Federal States nor the statutory insurances. The financ-
ing of private hospitals is based on treatment contracts with patients, which 
means that the patients are obligated to reimburse the hospitals themselves. Sub-
sequently the patients are later reimbursed by their private health insurance com-
panies. (Bundesverband Deutscher Privatkliniken e.V. 2017.) 
 
 
 
FIGURE 4. Dual hospital financing system (Ortenau Klinikum 2018, modified) 
 
In 2017, Germany spent 376 billion euros (11.5% of the GDP) on healthcare, 
indicating that Germany has one of the highest healthcare expenditures among 
the EU member states (Statistisches Bundesamt 2020). Unfortunately, the recent 
study of the German Hospital Institute (Blum et al. 2019) indicates that in 2018 
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40% of German general hospitals made losses. For 2020 only 17% of the inter-
viewed hospitals expect an improvement, and 44% even expect their economic 
situation to deteriorate.  
 
For many years there have been complaints that the dual financing system is not 
suitable for ensuring needs-oriented care due to conflicting interests between the 
funding bodies. While operating costs are rising steadily, the Federal States con-
tinue to reduce financial subsidies. (Klafki 2017.) According to the German Hos-
pital Federation (Deutsche Krankenhausgesellschaft 2019, 76), the investment 
rate of the Federal States decreased by nearly 50% compared to 1991. This sit-
uation often leads public hospitals to carry out unnecessary treatments or use 
expensive treatment methods in order to finance its operations through the health 
insurance funds. In a study by Roland Berger (2019), nearly 70% of the respond-
ents complained that their hospital is not investing enough. If investments are 
made, the primary motivations are to maintain or increase attractiveness for pa-
tients, enhance efficiencies, increase medical quality, and improve the ease of 
maintenance.  
 
In view of the current coronavirus crisis, hospitals are expecting to face even 
more severe financial problems in the foreseeable future. Many planned surger-
ies that would have provided important income are canceled in order to free up 
enough beds. The German government intends to support the health care system 
with up to ten billion euros to protect hospitals from economic damage as a result 
of their help in the crisis (Die Bundesregierung 2020). However, Josef Düllings, 
president of the Association of Hospital Directors, fears that the support will not 
reach all hospitals on time, which could cause many German hospitals to become 
insolvent in 2020 (Düllings & Zurheide 2020). 
 
 
3.2.1 Digitization in German hospitals 
 
In an international comparison, German hospitals are still far behind in the imple-
mentation of paperless systems. In the Electronic Medical Records Adoption 
Model (EMRAM), which ranks the level of digitization in healthcare facilities from 
0 (no paperless solutions) to 7 (fully digitized), Germany only receives a score of 
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2.3. Thus, it is below the European Union’s average of 3.6. The lack of digital 
transformation is particularly evident in the case of small hospitals with less than 
200 beds, which only reached a score of 1.3. The share of German hospitals that 
are still on level 0 in the EMRAM model is 40%, and only two hospitals met the 
requirements of level 6; none achieved level 7. (HIMSS Analytics 2019.)  
 
A closer look reveals that 74% of hospitals in Germany have a wireless internet 
connection. In those hospitals where Wi-Fi is available, it is only used in 70% of 
clinical organizational units, and less than 60% of the wards have mobile access 
to patient data. The majority of medical staff are provided with computers on 
ward-trolleys to access patient data; only 5% have the possibility to use 
smartphones and tablets. (Hübner, Esdar, Hüsers, Liebe, Naumann, Thye & 
Weiß 2020, 30.) In addition, a study by Schnürer, Wieland, Benthin, and Koch-
Büttner (2018) revealed that 80% of hospital staff rate HIS (hospital information 
systems) and cloud solutions as important, however, also 80% evaluate their own 
HIS as only moderately or even hardly satisfactory. A study by McKinsey 
(Hehner, Liese, Loos, Möller, Schiegnitz, Schneider, Oellerich, Plischke, Donath 
& Erk 2018) confirms that, instead of rolling out comprehensive digitization initia-
tives, the majority of German hospitals rely on pilot projects to validate the benefit 
of mobile devices and digital solutions for their facilities. Only if the pilot project 
proves to be successful, it will be considered to implement the tested system or 
application integrally. 
 
Stephani, Busse, and Geissler (2019, 29) see the causes for this hesitant devel-
opment in German hospitals firstly in the financial burden of investing in hard-
ware, software licenses, and staff training. Secondly, there are still doubts and 
skepticism about the benefits of IT-supported processes and their user-friendli-
ness. The criticism includes that displays are often too small, and the systems 
too slow or even crashing. Surveys among medical staff show that more than 
two-thirds are unsatisfied with the user-friendliness of the IT-systems available 
and that it does not matter what kind of HIS is used or from which provider it is. 
More important for the user-friendliness is whether it has been adapted to the 
local needs, harmonizes processes, and whether employees have been trained 
to use the system. (Stephani et al. 2019, 29-30.) Similar results were found in the 
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survey by McKinsey (Hehner et al. 2018). Besides insufficient financing, respond-
ents argued that the lack of compatibility or interoperability of IT systems, the lack 
of standardized processes, and data protection are the main reasons for the re-
strained development of digitization in German hospitals. In interviews, nurses 
from South and East Germany (Lefèvre 2020; Spreemann 2020) confirm that fi-
nancing, data protection, and staff training are the biggest challenges in digitiza-
tion, but at the same time, they express that new mobile devices and systems 
could save about one to two hours of their work per day. The main advantages 
are seen in the possibility of documenting promptly at the bedside, accessing 
patient records simultaneously, and communicating more efficiently.  
 
Regarding the patients, the study by Schnürer et al. (2018) shows that 60% of 
patients are not involved in digital processes at hospitals at all. For example, only 
15% of surveyed patients had access to information on their treatment. The study 
also found out that hardly any mobile IT equipment, such as tablets, is used by 
doctors and nurses to provide information, for example about conditions or treat-
ments. 85% of the respondents expressed a wish to be informed about current 
waiting times, followed by information and recommended behavior for the time 
after the hospital stay. Between 60% and 70% would also like to have the option 
of electronic appointment planning, information on the course of treatment, and 
status information for relatives, for example in the case of surgical operations. 
(Schnürer et al. 2018, 11-13.) 
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FIGURE 5. Current state of digitization in German hospitals 
 
One of the first steps taken by the German government to modernize the 
healthcare system was the introduction of an electronic health card (eGK) in the 
course of the “E-Health Act” (Act on Secure Digital Communication and Applica-
tions in Health Care). Since 2015 the eGK is the only valid proof of entitlement to 
benefits from the statutory health insurance. The eGK is a chip card that initially 
only stores mandatory administrative data such as name, address, date of birth, 
and insurance number. In the future, also so-called emergency data or medica-
tion plans can be stored on the health card; provided the insured person wishes 
to do so. All data is encrypted and can only be accessed if the cardholder author-
izes access and if the doctor has an electronic health professional card. PIN 
codes are only provided by the insurance companies if an insured person wants 
to use medical applications, such as storing emergency data on his or her health 
card. PIN codes are not required for checking data online or updating master 
data, nor for using the card as proof of insurance or for reading out emergency 
data. (gematik GmbH n.d.) 
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FIGURE 6. Front of German electronic health card (gematik GmbH n.d., modified) 
 
As of 2021, everyone with statutory health insurance can receive an electronic 
patient record (EPR) from their health insurance company, but in order for all 
patient data to be stored digitally, medical facilities must be connected to the 
telematics infrastructure (TI). The TI connects all stakeholders in the health care 
system and ensures a secure exchange of information. To fulfill this requirement, 
the German government implemented the “Act to Improve Healthcare Provision 
through Digitalization and Innovation” (DVG) in January 2020. With this act, phar-
macies and hospitals will be obliged to be connected to the TI latest until the end 
of 2021. The three main focus areas of this act are the prescription of eHealth 
apps, online video consultations with medical professionals, and access to pa-
tient records from anywhere. Healthcare apps are already used by half of the 
German patients, and from now on, doctors will be able to prescribe such apps 
at the expense of statutory insurances. (Bundesministerium für Gesundheit 
2019a, 2019b, 2020.)  
 
Another important contribution to the digitization of German hospitals is made by 
the Medical Informatics Initiative (“Medizininformatik-Initiative”), a project sup-
ported by the Federal Ministry of Education and Research that brings medical 
professionals, IT professionals and scientists of various disciplines together. The 
goal of this initiative is to digitally connect all patient data that is generated during 
a hospital stay and thus improve research opportunities and patient care. The 
exchange of data from patient care and clinical and biomedical research across 
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institutions opens up the possibility for scientists to conduct research that will en-
able faster and better healing of diseases in the future and simultaneously im-
proves the treatment of individual patients. All university hospitals in Germany 
are currently working together with research institutions, companies, health in-
surance companies and patient representatives to develop the framework condi-
tions so that research findings can reach patients directly. Until 2021 the Federal 
Ministry of Education and Research plans to invest around 160 million euros in 
this funding program. (Medizininformatik-Initiative 2019.)  
 
When taking a look at the innovators and thought leaders among the German 
hospitals, several rankings continuously prove that the Charité – Universi-
tätsmedizin Berlin is the best clinic in Germany and one of the best in the world. 
According to the yearly hospital ranking of the FOCUS magazine (Niehaus 2019, 
58), Charité leads in 21 clinical areas, including Alzheimer's, various cancers, and 
trauma and spine surgery, and convinces with an excellent standard of patient 
service. Moreover, the Charité is working on a completely digital structure of med-
ical records and aims to achieve level 7 of the EMRAM model by 2028 (kma-
online 2019). Based on the hospital ranking, Charité is followed by Universitätsk-
linikum Carl Gustav Carus, Universitätsklinikum Heidelberg, Klinikum der Univer-
sität München and Universitätsklinikum Tübingen. An extract of the hospital top 
list can be found in appendix 1. (Niehaus 2019, 58.) Regarding the digital trans-
formation, the Universitätsklinikum Essen and the Universitätsklinikum Hamburg-
Eppendorf are considered pioneers in digitization. In fact, the Universitätsklinikum 
Hamburg-Eppendorf was the first university hospital in Europe to introduce the 
digital patient record in 2011, while the clinic in Essen strives to become the first 
smart hospital in Germany. Artificial intelligence, robotics, and most modern IT 
solutions are being implemented to automate and thereby improve clinical pro-
cesses. (Niehaus 2019, 16-20.)  
 
Concerning the private German hospitals, Helios Kliniken is leading the top list 
as the largest and best-rated clinic group. Helios is closely followed by Asklepios 
Kliniken, Sana Kliniken, Rhön Kliniken, and Ameos Gruppe (see appendix 2). 
(praktischArzt 2020.) All of these top clinics have been investing in the digitization 
of their facilities over the past years. In 2015 Helios launched the first German 
accelerator hub for founders and start-ups developing digital solutions such as 
26 
 
patient apps for hospitals (Helios Kliniken n.d.), and Asklepios have set them-
selves the goal to be fully digitalized by 2024 and become a market leader in 
digital healthcare services (Asklepios Kliniken n.d.). 
 
By comparison, smaller regional and rural hospitals are in a worse position than 
the university hospitals and private clinics. Although small hospitals (with less 
than 200 beds) tend to invest more in digitization in relation to their total annual 
budget, the vast majority of their digitization projects are not implemented suc-
cessfully. Only every third small hospital in Germany has a digitization strategy. 
(Hehner et al. 2018; Hüsers 2020.) 
 
Interviews among CEOs of German hospitals reveal that the decision-making 
process about IT investments is usually initiated by new legislations or the IT 
department, and in rarer cases by the top management or doctors. The final de-
cision is either made by the CEO or by a collaboration of CEO, CIO, and end-
users such as doctors. If the facility belongs to a hospital group, it must comply 
with the group strategy, which means that the parent company holds the final 
vote. (Thye, Hübner, Hüsers & Babitsch 2017, 114.) Hüsers (2020) adds that also 
medical management and nursing management can propose the implementation 
of new systems or devices and play an important role in the decision-making pro-
cess. Since the success of the installation of new IT solutions will ultimately de-
pend on the satisfaction of the end-users, doctors and nurses are usually the 
primary points of contact for IT firms such as Company X. However, the final 
decision depends on business management, since they are responsible for the 
hospital finances. New IT investments require a large budget and unfortunately, 
hospitals in Germany do not receive special investment promotions for the acqui-
sition of new software, systems, or digital devices. 
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FIGURE 7. Decision-making process about new IT products in German hospitals 
 
 
3.3 Competitors 
 
 
3.3.1 Company A 
 
Segment A is a strategic growth segment of Company A, a large telecommuni-
cations company in Europe. It was founded in 2014 and is structured into Seg-
ment A and Segment B. Company A offers different digital solutions for different 
stakeholders in the healthcare system, including health insurers, hospitals, doc-
tor’s offices and laboratories. The hospital portfolio comprises, among other 
things, Product A, the accompanying Product B, and Product C. Product A is 
used daily in more than 200 hospitals in Germany and 1,000 hospitals worldwide, 
and around 100 clinics even confide their entire IT-system to Company A. Product 
C can be used on a bedside terminal and offers patients TV, movies, and internet 
access to make the hospital stay as pleasant as possible. (Competitor A.) 
 
 
3.3.2 Company B 
 
Company B was founded in 1995 in Germany and develops hardware and soft-
ware solutions for hospitals. The company’s product portfolio includes mobile de-
vices with customizable user interfaces, and Product D. With a market share of 
75%, Company B is a market leader of infotainment solutions in Germany. From 
a global perspective, more than 200,000 of their mobile devices are in use by 
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100,000 customers. In 2019, Company B employed 140 people and achieved a 
turnover of 20 million euros. The mobile devices offer patients the possibility to 
order meals, control the heating, get information about their treatment or simply 
entertain themselves. The mobile devices can also be used by hospital staff to 
display medical content without data protection concerns. Product D can be used 
by both patients and hospital staff on personal or professional devices. It enables 
patients to check-in on their own, upload documents, or access information about 
the hospital and the team before starting the treatment. During the stay, Product 
D can be used for entertainment, to support the therapy or collect feedback, and 
after the stay, doctors can follow-up with their patients. Thus, it can be integrated 
into the whole patient journey and thereby optimize the processes and resources 
in hospitals. (Company B a; Company B b.) 
 
 
3.3.3 Company C 
 
Company C is a German company founded in 2002. The offering includes mobile 
devices and bedside terminals and a hospital app platform that allows a digital 
connection of patients and clinical staff throughout the entire care journey. Mean-
while, Company C installed more than 18,000 devices in over 70 hospitals in Eu-
rope and the United States. Company C sources its mobile devices from a South 
Korean manufacturer and the bedside terminals from a Taiwan based hardware 
manufacturer. The app accompanies patients from the moment they are signed 
up for treatment until they are completely recovered. During the stay at the hos-
pital, the doctors can monitor the condition of the patients, while the patient can 
stay in touch with the family and use the entertainment services. The bedside 
terminals offer the possibility to create different profiles for different users, i.e. 
patients, nurses, and doctors. (Company C.) 
 
 
3.3.4 Company D 
 
Company D is a software company founded in 2012 in Germany that developed 
Product E. Product E is a mobile device with software specially developed for 
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medical practices that enables paperless anamnesis and maintenance of elec-
tronic patient files. Information sheets can be displayed in the native language of 
the patient and then translated into German, and regular updates ensure that the 
forms are always adapted to new developments such as legal requirements. Ac-
cording to the company’s website, customers can obtain Product E already for 
less than five euros per day. (Company D.) 
 
 
3.3.5 Company E 
 
Company E was founded in 2008 in Germany, but nowadays has its headquarters 
in New York, United States. The company has subsidiaries in Germany, Switzer-
land, Austria, France, Spain, Gibraltar, and the United Arab Emirates, and spe-
cializes in customized digital solutions for hospitals. The software and hardware 
platform of Company E integrates patient check-in, infotainment, digital meal or-
dering, bed and room control, nurse calling, and access to patient data onto one 
single platform. In addition, Company E provides innovative bedside terminals, 
ward trolleys, and an app that can be used by patients on their own mobile de-
vices instead of bedside terminals. (Company E.) 
 
 
3.3.6 Company F 
 
Company F was founded in 1987 in France and has subsidiaries in Germany and 
the United States. The company provides customizable hardware solutions for 
professional use and has developed more than 250 products. Over 7,000 cus-
tomers in 50 countries are using mobile devices tailored to their individual industry 
needs. Among others, the customers include construction, logistic and forestry 
companies, as well as police and hotels. (Company F.) 
 
 
3.3.7 Company G 
 
Company G is a leading manufacturer of industrial and medical computers, 
screens, and mobile devices. The company was founded in 2010 and has its 
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headquarters in Charlotte, United States. Over the years, Company G estab-
lished various offices in Europe and Asia and continues to expand its global pres-
ence and product range to support the vision of becoming a global top brand. 
According to the CEO, industrial computers are sold at a very high price while 
consumer computers on the other hand are built to only last about one year. For 
this reason, Company G manufactures its devices in Taiwan where low costs 
meet high levels of quality. (Company G.) 
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FIGURE 8. Comparison of two main competitors 
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3.4 Porter’s Five Forces 
 
According to Porter (2008, 25), competition does not only occur among direct 
competitors but also among four more forces; namely customers, suppliers, po-
tential entrants, and substitute products. Understanding how these five forces 
jointly shape competition is crucial for the strategy of both existing companies 
and new entrants to the market (Porter 2008, 26-28).  
 
 
3.4.1 Competitive rivalry 
 
The main competitors for Company X in the German hospital market are medium 
to large-sized hard- and software companies that have an established presence, 
years of experience, and a loyal customer base in the market. The major threat 
comes from Company A since it already had a strong presence in around 50 
countries before expanding its business to the healthcare sector and with the 
founding of the new strategic segment Segment A, the company quickly became 
a leading provider of healthcare ICT in Germany. The main focus lies on the in-
stallation and maintenance of Product A and the accompanying Product B, but 
besides, the company is also actively equipping hospitals with mobile devices 
from other manufacturers. The biggest competitive advantage of Company A, 
besides having a good reputation and solid customer base, is that its offering 
covers the entire IT value chain, not only of hospitals, but also of other key players 
in the healthcare market. There might be a chance to overcome this threat by 
partnering with Company A. A partnership could be established on the base that 
Company A specializes in software solutions and only provides hospitals with 
mobile devices in order to enhance the customer experience, but the combination 
of mobile devices and software services of Company X could be an even better 
complement to this solution. 
 
Other direct competitors that Company X needs to pay attention to are Company 
B, Company C, Company D, and Company E, which are all based directly in 
Germany and target primarily the hospital sector. In addition, Company F and 
Company G offer a range of industry products and services that can easily be 
customized to meet the needs of hospitals.  
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The closest resemblance to the product offering of Company X comes from Com-
pany B and Company C. Both companies provide mobile device service that can 
be used by both medical staff and patients, and Company B is even manufactur-
ing their own devices. The difference to Company X is that both companies are 
providing different types of mobile devices and their software is solely tailored for 
the needs in hospitals. Besides, both companies developed their own apps that 
can be used by patients and the hospitals to support the patient journey and fa-
cilitate the processes and communication between both parties.  
 
 
3.4.2 Buyer power 
 
The potential customers of Company X have different providers to choose from 
and almost all of them offer customizable services that can be integrated into the 
existing systems at the hospitals. The internet is an efficient tool to compare the 
providers and their portfolios since every company has its own website that show-
cases the company and its products and services. This includes references to 
past projects and positive customer stories. In addition, the content on most web-
sites is available in German which adds a lot to the convenience of potential Ger-
man customers. Since public hospitals in Germany rely entirely on the investment 
financing of the Federal States, they are highly sensitive to prices. Despite seek-
ing top-quality products and services, there is a high probability that hospitals 
would look for more affordable alternatives if the price of a certain proposal ex-
ceeds their budget. Also, the likelihood that hospitals that already have a digital 
solution would switch to a new provider is fairly low since the integration of a new 
solution involves a great amount of time and effort.  
 
 
3.4.3 Threat of substitution 
 
Traditionally, healthcare professionals have relied on paper forms for patient 
check-in, documentation, medication plans, prescriptions, feedback, and so forth. 
New reforms, such as the DVG oblige hospitals to adopt digital solutions and 
create a paperless environment. Therefore, the threat of substitution by paper 
forms is very likely to decrease, however, it should not be completely ignored yet.  
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More considerable threats are presented by stationary and mobile computers that 
allow doctors and nurses to access patient data. Results of the study by Hübner 
et al. (2020, 50) show that stationary computers are available in all facilities and 
mobile computers on ward-trolleys are used by 40% of the respondents. One 
advantage of computers and mobile workstations is that they can accommodate 
mice and keyboards which offer higher ease of use than mobile devices. The 
increased comfort due to keyboards, mice, and large screens could beat smaller, 
portable devices in the decision-making.  
 
Another threat of substitution is posed by apps and systems that can be used on 
personal devices of both clinical staff and patients. Worldwide nearly 320,000 
mHealth apps are available and more than 60% of people have downloaded such 
an app (Mobius MD 2019). About 65 million Germans have a smartphone (Brandt 
2019) and in most hospitals it is nowadays permitted to use them. Patients can 
simply use their own devices to find information or entertain themselves, thus 
substitute the service of Company X. 
 
 
3.4.4 Threat of new entrants 
 
The demand for digital solutions in German hospitals is expected to grow be-
cause of legal requirements and the need for more efficient processes. This 
makes the market attractive for both large technology companies and start-ups 
from Germany and abroad. Large companies can easily expand their portfolio to 
healthcare solutions by developing their own hard- or software or by partnering 
with other specialized companies. Thanks to the DVG, health insurance compa-
nies will have the possibility to support the development of digital innovations 
financially so that successful approaches can be quickly transferred to the 
healthcare system (Bundesministerium für Gesundheit 2020a). In the future, this 
will give start-ups the chance of a secured funding and a quicker admission pro-
cedure to the market after proving the medical quality and economic efficiency of 
their product. Thus, there is already a significant threat of new entrants which is 
likely to increase even more in the close future. 
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3.5 Potential distributors and partners 
 
 
3.5.1 Company H 
 
Company H is a German IT service provider with more than 30 years of experi-
ence in the development and distribution of IT solutions for the German 
healthcare market. In addition to its head office in Brandenburg, the company has 
15 subsidiaries and nearly 30 partners across Germany. The product portfolio of 
Company H includes their own medical office software, document manager, and 
an app solution that allows personnel to access patient data comfortably on mo-
bile devices, and in addition, Company H distributes the product of Company D. 
The company offers a service and support hotline and regularly hosts training 
sessions and seminars about their products. (Company H.) 
 
Company H convinces as a potential distributor due to long market experience, 
a well-developed network of German healthcare providers, and geographic cov-
erage of the entire country. The company’s portfolio further includes complemen-
tary product lines, a similar mobile device service that provides Company H with 
product experience, and reliable customer service. Shortcomings can be seen in 
the fact that Company H is distributing a competitive product and that the com-
pany has no working experience with other foreign exporters. 
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FIGURE 9. Distributor evaluation of Company H 
 
 
3.5.2 Company I 
 
Company I is a company that was founded in 2015 with the mission to support 
clinics and practices in setting up and operating IT solutions. The company has 
three offices as well as five branch offices and partners in the Midwest of Ger-
many and serves clients nationwide. The portfolio comprises consultations for 
medical professionals, IT systems, software, hardware, and the product of Com-
pany D. (Company I.) 
 
Company I has been operating for six years, but its team members that come 
from both business and medical backgrounds have a much longer history in the 
German healthcare market. Company I has experience in providing German hos-
pitals and practices with IT services tailored to their individual needs and the com-
pany has the ability to serve clients across the whole country. In addition to soft-
ware solutions, Company I also have experience with the distributions of hard-
ware products. Simultaneously this can be seen as a shortcoming since Com-
pany I also distributes Product E, which is a competitive product for Company X.  
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FIGURE 10. Distributor evaluation of Company I 
 
 
3.5.3 Company J 
 
Company J is a group of companies that was founded in 1982 in North Rhine-
Westphalia, and offers a broad portfolio of IT infrastructures, IT system solutions, 
applications, and software. With subsidiaries in nine German cities, Company J 
is nationwide available as a leading IT service provider. The main focus area of 
Company J’s services is the healthcare industry, which they support with Wi-Fi 
installations, hard- and software solutions for the EPR, content management sys-
tems, IT security, storage, network installations, and IT ward trolleys. 
 
Company J is looking back on decades of market and product experience and 
has product lines that are complementary to Company X’s service in their portfo-
lio. The company is serving a nationwide client base with both soft- and hardware 
solutions and round-the-clock customer service which makes Company J a fa-
vorable choice as a distributor for Company X. Company J is actively participating 
in trade fairs, roadshows, and conferences and organizes training sessions and 
webinars for its customers. The only shortcomings are the wide range of different 
products that Company J is offering, the low probability that the company would 
drop competing product lines, and the lack of experience in working with foreign 
exporters.  
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FIGURE 11. Distributor evaluation of Company J 
 
 
3.5.4 Company K 
 
Company K is a hospital technology company founded in 2016 in Berlin. The 
products range from asset and patient tracking to process analyses, temperature 
monitoring, and bed management. Company K’s software is developed for both 
mobile and stationary devices and collects live data via wireless networks. The 
hardware includes signal receivers that can be attached to hospital assets such 
as beds and wheelchairs in order to track them and manage all assets efficiently. 
(Company K.) 
 
Company K is a relatively young, but fast-growing company that is actively look-
ing for partners that can complement its solution. The company is working closely 
with customers from hospitals to develop and test their new products in order to 
ensure an uncomplicated introduction and high level of acceptance. Company K 
could be an ideal partner for Company X since they share the same objectives 
and have complementary product lines. Apart from that is Company K familiar 
with the target market and has established relationships with target customers in 
German hospitals. 
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FIGURE 12. Distributor/ partner evaluation of Company K 
 
 
3.5.5 Company L 
 
Company L was founded in 2007 in Germany and offers different kinds of medical 
technology systems, including staff training and maintenance. The portfolio con-
tains hardware such as digital medical devices, software programs for medical 
practices, Product E, and network installations and configurations. Company L’s 
team supports customers on the phone, as well as on-site with maintenance, de-
vice testing, training sessions, and consultations. (Company L.) 
 
Looking at Company L, the company has great experience in the German 
healthcare market and digital solutions, and above all, is very active in supporting 
its customers. On the downside, it has to be recognized that the company is fo-
cusing on practitioners that are running their own practices rather than on hospi-
tals. Furthermore, Company L distributes the product of one of the competitors of 
Company X.  
 
40 
 
 
 
FIGURE 13. Distributor evaluation of Company L 
 
 
3.6 SWOT analysis 
 
The SWOT Analysis is an efficient method to identify the strengths, weaknesses, 
opportunities, and threats of a company and its target market, and thereby it sup-
ports the company in making a business decision. A SWOT Analysis should be 
performed before committing to new company activities, such as entering a new 
market, in order to develop a strategy to overcome weaknesses and threats and 
leverage strengths and opportunities. (Schooley 2019.) 
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FIGURE 14. SWOT Analysis of Company X 
 
Company X has a wide range of strengths that could facilitate the establishment 
of the company in the German hospital market. First of all, Company X offers a 
comprehensive service that includes both hard- and software and takes care of 
updates and data protection on its own. Another advantage is that the devices 
can be used by both patients and staff because the content can be customized 
for different user groups. The special cover prevents the devices from breaking, 
and in addition, the devices have an antibacterial screen protector. To lend a 
device, the user must authenticate himself. This frees up valuable time for the 
medical staff since they do not have to take care of data privacy issues, or charg-
ing, updating and lending of the devices. Moreover, the service enables full cus-
tomization of the content that is displayed on the devices and can be integrated 
into other systems as well. In the long-term, this service is very cost-efficient and 
42 
 
can save a high percentage of the IT costs since it requires little maintenance 
and support and the onboarding and staff training is very easy. Besides having a 
strong product, Company X already received a lot of positive reviews from Finnish 
customers that integrated the service into their hospitals. Such references from 
satisfied customers reinforce the brand image and are particularly credible and 
convincing. Thanks to the feature that deletes all user data after usage of the 
devices automatically, Company X is less vulnerable to changes or tightening in 
data protection laws. 
 
Despite possessing a lot of strengths, Company X also shows some weaknesses. 
The missing experience in the German healthcare market can be considered the 
biggest weakness of the company which is simultaneously the hardest to over-
come. This goes along with the fact that Company X has no physical presence 
outside of Finland, making it dependent on the expertise of partners and distrib-
utors. The service itself is expensive to purchase and due to their limited invest-
ment budget, hospitals could be deterred to acquire the service of Company X. 
Regarding the functionality of the devices, it is important to keep in mind, that 
Germany is digitally not as advanced as most Nordic countries and that not every 
hospital has Wi-Fi or satisfactory IT-systems yet. Some competitors provide de-
vices that can be attached to a monitor arm on the bedside which increases com-
fort and user-friendliness for patients. Since Company X’s devices do not have 
such a feature yet, users always have to hold them in their hands or place them 
on a flat surface which could be seen as another weakness since it reduces com-
fort. Further, Company X offers only one type of mobile device, but as the re-
search and interviews show, hospitals are relying on different devices to com-
municate and entertain patients. According to the interviewed nurses (Lefèvre 
2020; Spreemann 2020), televisions are still regarded as the best devices for 
patient entertainment and phones and tablets are favorable means of communi-
cation for the staff. Also, contrary to other companies, Company X does not pro-
vide its own apps or HIS that could further support the optimization of processes 
in hospitals. The company’s website is very modern and functional; however, the 
content is only available in Finnish and English. Multilingual websites have be-
come a necessity for companies in the internationalization process because they 
expand the reach, prove customer-centricity, and build trust (Fowler 2018). Con-
sidering that the vast majority of internet users prefer to browse and buy in their 
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native language (CSA Research 2014) and that there are over 130,000 German 
speakers worldwide (Devlin 2018), Company X seems to pass up a great oppor-
tunity here. 
 
Regarding the hospital market, Germany offers many opportunities for compa-
nies like the commissioning company. Not only is it a very large market, but at 
the same time the need for digital solutions is still high. The current lack of digiti-
zation and the high dissatisfaction with the user-friendliness of existing devices 
and IT-systems provides the right basis for Company X to introduce its offering 
as user-friendly, customizable, and time-saving service. Furthermore, new legal 
requirements such as the DVG are accelerating the digital transformation in the 
German healthcare market and oblige healthcare providers to convert their sys-
tems and processes from analog to digital. Consequently, this leads to a higher 
need for mobile devices in hospitals and other healthcare facilities. Furthermore, 
both local and foreign start-ups have the possibility to rely on the assistance of 
accelerators or start-up centers in entering the healthcare market in Germany. 
Examples for such support are Flying Health, health innovation hub, or Medical-
Mountains GmbH. Flying Health is a Berlin-based ecosystem that supports digital 
health start-ups in all stages by connecting them with the right partners, helping 
them participate at events, or initiating pilot projects (Flying Health n.d.). The 
health innovation hub is a platform of the Federal Ministry of Health that aims to 
identify, evaluate and develop digital solutions and applications for medical care 
and builds bridges between start-ups and relevant stakeholders in the healthcare 
sector (hih-2025 n.d.). MedicalMountains is located in a cluster of medical tech-
nology companies in South Germany and considers itself to be an initiator and 
bridge builder that brings players of the industry together. It has set itself the goal 
of networking small and medium-sized companies, promoting their growth and 
further expanding their competitive advantages regionally, nationally, and inter-
nationally. (MedicalMountains n.d.) 
 
Nevertheless, Company X will also have to face major challenges in the German 
market. The main threat is posed by the existing competitors that already have a 
secured position in the healthcare market, as described above. Besides strong 
competition, the complex funding system of German hospitals may present an 
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entry barrier for foreign start-ups. The dual financing system makes public hospi-
tals dependent on the support of the Federal States, while private hospitals must 
bear all costs alone. For this reason, the hospital management is assessing costs 
and different options carefully before making a purchase decision and thereby 
start-ups have the disadvantage that they usually do not have an established 
presence and reputation in the market yet. Moreover, the current coronavirus ep-
idemic is afflicting the entire healthcare system and causes hospitals to focus 
only on their indispensable needs. Once the crisis has flattened and restrictions 
have ended, investment projects could be planned to make faster progress in 
digitization in order to avoid some of the shortcomings in the future. (Hüsers 2020; 
Nelde 2020.) On April 27, 2020 the Federal Health Minister introduced a plan 
consisting of ten points to reinforce health authorities in Germany. These points 
include, amongst others, the digitization of the reporting channel of new con-
firmed cases, a program for digital upgrading and equipping of the public health 
authorities, and a so-called quarantine diary as a platform for health authorities. 
(Bundesministerium für Gesundheit 2020b.) If, and when this plan will enter into 
force is uncertain, but it exemplifies the efforts of the German government to im-
prove the situation in healthcare in the future. Nonetheless, the end of the epi-
demic is unpredictable and the damage incalculable. This is why the only way for 
Company X to overcome this challenge in the German healthcare market is to 
wait and see how the situation develops. 
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4 MARKETING MIX 
 
 
4.1 Product 
 
The product of Company X is a combination of mobile devices and software. For 
customers in the hospital sector it is crucial that new digital products support the 
clinical processes and, in the best case, increase their efficiency. Bad experi-
ences in the past have led decision-makers to evaluate the needs of the hospitals 
more carefully, taking the opinions of other stakeholders into account. End-users 
such as doctors and nurses are explicitly expressing their requirements and ex-
pectations and have a strong influence on product selection. 
 
When specifically asked about the functionalities of mobile devices, interviewed 
nurses stated that devices should be able to contain patient records and labora-
tory values, all of which should be interconnected. Further, a good camera for 
wound documentation is an essential element. Ultimately, the use of shared mo-
bile devices must lead to faster communication between the wards, facilitate pa-
tient documentation, and enable faster and clearer diagnoses. (Spreemann 2020; 
Lefèvre 2020.) Nelde (2020) adds to that, that many medical facilities have com-
plained about the theft of their mobile devices in the past. Under consideration of 
this fact, it becomes apparent that reliable anti-theft protection is another signifi-
cant aspect of this product in a hospital environment.  
 
 
4.2 Price 
 
The service of Company X comes at a premium price; however, customers can 
save costs and other resources in the long-term. When selling to customers out-
side of Finland, transportation costs, profit margins for distributors, and taxes will 
be added to the price. Customers in the hospital segment are bound by limited 
investment budgets and therefore highly price sensitive. Moreover, the acquisi-
tion of a new IT-product or service can imply additional efforts such as staff train-
ing and restructuring of processes and systems. Keeping these overall costs in 
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mind, decision-makers are evaluating different alternatives cautiously and must 
be fully convinced before making a purchase decision.  
 
 
4.3 Place 
 
Company X has decided to export its services indirectly using distributors in the 
target markets, and the same strategy will be applied to enter the German 
healthcare market. Consequently, Company X will not have any physical pres-
ence in Germany. All activities required to pass the product to the customer will 
involve a third party as a channel intermediary. For this reason, it is crucial to take 
the needs and expectations of both the company and the customers into account 
when choosing a distributor or partner in the new market. 
 
 
4.4 Promotion 
 
While scientific journals, congresses, and discussions with colleagues are still the 
main sources of information for German doctors (Eckmann 2018), they are in-
creasingly active on social media. Social media platforms offer doctors the pos-
sibility to network with colleagues from all over the world, convey specialist infor-
mation, present themselves, and acquire patients (healthcare-in-europe 2019). 
Besides doctors, also nurses and the nursing management inform themselves 
about current topics concerning digitization and the healthcare sector out of their 
own motivation. Specialist journals and magazines that are specially targeted at 
nursing staff are a commonly used medium. (Hüsers 2020.) Both social media 
and printed media prove to be effective means to educate target customers in 
German hospitals about new products, services, or solutions and will, therefore, 
be important promotional channels for Company X.  
 
In order to get physically in contact with different stakeholders of the German 
healthcare market and gain personal experiences on the new target market, local 
events such as trade fairs are an excellent channel for Company X. One of the 
most popular platforms for digital healthcare is the DMEA (Digital Medical Exper-
tise & Applications) trade fair that is held once a year in Berlin. With more than 
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11,000 attendees from around 50 countries, it is the largest event for digital health 
in Europe. At this trade fair visitors from all over Europe come together to learn 
about current developments and new products and make valuable contacts. 
Since eight out of ten visitors of the DMEA are decision-makers, this is the perfect 
platform for Company X to meet potential customers, network with distributors 
and partners, and introduce their service for hospitals. (Messe Berlin 2020.)  
 
Besides DMEA, the MEDICA is a leading trade fair for medical technology. It is 
held once a year in Düsseldorf and showcases new trends, products, and solu-
tions for the healthcare market. In 2019 the trade fair counted 5,500 exhibitors 
and 121,000 visitors including practitioners, nursing staff, hospital managers, and 
technical managers. The venue is divided into five segments, namely electromed-
icine / medical technology, information and communication technology, diagnos-
tics, orthopedic technology, and commodities and consumer goods. Exhibitors in 
the ICT segment get the chance to show and explain connected health and health 
IT solutions and find out where the digital journey is heading in different countries. 
(Messe Düsseldorf 2019.) 
 
Another great meeting point for IT companies, medical technicians, and institu-
tions from the healthcare sector is the eHealth Europe fair in Freiburg. The or-
ganizer offers start-ups free consultations and a separate area in the hall at re-
duced rates. (eHealth Europe n.d.) Such trade fairs offer an excellent opportunity 
for Company X to find connections in the new target market, meet potential cus-
tomers, partners and distributors and identify trends and competitors.  
 
Even though Company X will not establish a physical presence in the target mar-
ket, the website will represent the company online and serve as a tool to com-
municate with customers. It provides visitors with all the information about the 
company and its products. Visual elements grab the attention and customer tes-
timonials prove credibility, expertise, and quality. However, the content is only 
available in English and Finnish right now. In order to strengthen its brand image 
and build trust with the new target audience, Company X might need to consider 
translating the content into German. The biggest benefits of having a multilingual 
website are a wider reach, enhanced user experience and the proof of customer-
centricity (Comben 2016). 
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Once the networks and partnerships are established, pilot projects can prove 
useful in the promotion of the service in the new target market. The goal of pilot 
projects is to get the service tested by some of the target customers, collect their 
feedback and use the obtained information to promote Company X and its service 
to the entire market in Germany. The results of the pilot projects will enable Com-
pany X to prove the benefits of their service and mobile devices for German hos-
pitals and provide them with valuable experience on the behavior and expecta-
tions of their new customers.  
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5 CONCLUSION 
 
 
The main objective of this thesis was to investigate how a Finnish IT startup could 
successfully enter the German hospital market. This included determining the 
characteristics of the German hospital market, the needs and expectations of po-
tential customers, and the strengths of the competition. Furthermore, potential 
distributors and partners, as well as effective marketing communication channels 
were researched. 
 
Since the prerequisite for any mode of market entry is a solid understanding of 
the target market, the first step was to conduct a market analysis. The results of 
the analysis prove that the German healthcare market is particularly large and 
complex and that it is influenced by different internal and external factors. Key 
players in the market are the nearly 2,000 private and public hospitals, ambula-
tory practices, health insurance companies, and the state. The observation 
showed that nowadays, the lack of qualified personnel, cost and efficiency pres-
sure, and digitalization are the strongest trends in the German hospital sector. 
Concerning digitization, the findings proved that German hospitals still remain 
underdeveloped in an international comparison. Although hospitals generally see 
digitization as an opportunity, low investment capitals hinder most facilities from 
utilizing these opportunities. Furthermore, the use of disruptive or unsatisfactory 
systems and products in the past caused medical staff to become more hesitant 
towards the acquisition of new IT solutions. Pilot projects are a common means 
of testing digital products before they are introduced in their entirety to the hospi-
tals and help to overcome the hesitation. 
 
In order to improve the digitization process of the healthcare system, the German 
government has passed several acts that will open up new possibilities for 
healthcare providers and simultaneously oblige them to connect to the tele-infra-
structure. Further actions to catch up digitally are taken by the Medical Informatics 
Initiative, in which all university hospitals are involved. University hospitals are 
seen as the forerunners in developing and implementing digital solutions and thus 
play an important role as innovators in the German hospital market. Also, the 
private hospitals are sophisticated in implementing digital solutions and mostly 
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have clear goals for the transition from analog to digital technology in their facili-
ties. Smaller and regional hospitals, on the other hand, are less advanced and 
generally do not have set any specific objectives or digitization strategies yet. 
 
The impetus to implement new technologies in hospitals is usually given by new 
legal requirements, the IT department, or occasionally the medical staff. As end-
users, doctors and nurses are increasingly taking part in the decision-making pro-
cess, but the final decision lies with the top management that is responsible for 
the hospital’s finances. The decisive criterion for choosing a new IT solution is its 
user-friendliness and the benefits for the hospital routine. In the specific case of 
mobile devices for shared use, the devices must be able to provide the staff reli-
ably with all patient data, ensure data protection, have a good camera for wound 
documentation, contribute to a faster communication between different wards, 
and have protection against theft. 
 
The research revealed that the German healthcare market is very competitive 
since several technology companies are specialized in serving German hospitals 
with mobile devices and apps, software, and systems that support the daily hos-
pital routine of medical staff and patients. Their biggest strengths are a strong 
foothold in the German healthcare market and products and services that are 
explicitly targeted at customers in the healthcare sector. In addition, the German 
government supports start-ups in introducing new solutions to the market, while 
several hospitals lead their own innovation projects, which increases the threat 
of new entrants and substitution for the service of Company X.  
 
During the market research it was further found that the number of businesses 
that are solely specializing in the distribution of mobile devices and IT services is 
still very limited. The reason might be that digital solutions have not yet been 
consistently established in German hospitals. However, there are many software 
companies that are showing interest in partnerships with providers of other prod-
ucts that could complement their own offering and thus provide customers with 
an enhanced solution.  
 
The best places to meet such partners are trade fairs in Germany that have a 
focus on innovations and digital solutions for the healthcare market, such as 
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DMEA and MEDICA. These are also the ideal platforms to showcase the own 
products to potential customers and make important connections.  
 
 
5.1 Recommendation 
 
As the findings of this research show, there are a lot of opportunities for tech start-
ups in the German healthcare market and the hospital sector in particular. Many 
hospitals are facing a number of challenges in digitization: financing, user-friend-
liness, data protection, staff training, and protection against theft of digital de-
vices. Company X has the potentials to solve all these challenges with its unique 
service.  
 
Since all of the German university hospitals are actively working on promoting 
digitization and process optimization, they are very likely to be open to new digital 
solutions. At the same time, they mostly have some type of digital systems and 
devices already in use, which is the reason why Company X should consider 
approaching smaller, regional hospitals first. They are generally less advanced 
than university hospitals and private hospitals and offer therefore the right starting 
point to introduce the innovative service of Company X to optimize clinical pro-
cesses and contribute to the entertainment of patients. The most important con-
tact persons in hospitals that Company X should approach first are nursing man-
agement and doctors. As potential users of the devices, they are the ones who 
must be convinced about the service, and they also have the power to suggest 
the implementation of the service in their facility.  
 
The first recommended step in entering the hospital market is to attend events 
such as medical trade fairs in Germany in order to meet potential customers, 
distributors, and partners and start to build a network in the new target market. 
The most recommendable medical trade fairs for Company X are DMEA in Berlin, 
MEDICA in Düsseldorf, and eHealth Europe in Freiburg. At the same time, scien-
tific journals for doctors and nurses should be considered as important marketing 
communication channels for introducing the company to German hospitals and 
educating potential customers about the service. This could be done by publish-
ing articles about success stories that Company X already achieved in other 
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countries or pilot projects in Germany. Besides, it would be worth considering 
offering the website content in German in order to be more appealing to prospects 
that wish to gain more information about Company X.  
 
As for the distributors in the German market, it is advisable to establish partner-
ships with IT companies that are specializing in hospital management systems 
and software, and already have a customer base in the hospital sector. Such 
companies have the right knowledge about the market, experience with the target 
customers and they have product lines that are complementary to what Company 
X is offering. Moreover, they already have a trusted reputation among potential 
customers, hence, a partnership with such companies could facilitate the intro-
duction of the service of Company X remarkably. Help in this process could be 
obtained from accelerators, such as start-up centers and hubs that are special-
ized in digital innovations in the healthcare sector. Such accelerators have the 
right experience and contacts with different stakeholders in the market which 
could facilitate the preparations for market entry significantly. 
 
Once the necessary networks and agreements are established, the next step 
should be to start a pilot project in one of the smaller hospitals. A pilot project will 
enable Company X to learn firsthand about the customers, their processes and 
requirements, and predict how well the target user group will adopt the service. 
Feedback collected during the pilot project about features, performance, and user 
experience is necessary for the commissioner to take corrective actions to man-
age and minimize possible risks. Ultimately, the results will not only prepare the 
company for the launch but also serve as proof of the benefits of the service. 
 
The final step, after conducting successful pilot projects, will be the launch of 
Company X and its service to the entire hospital market in Germany. Here too, it 
will be essential to stay in close contact with the users of the service and collect 
feedback on a regular basis to ensure the satisfaction of the new customers. 
 
In all of this, it should be kept in mind that it takes time to build a network in the 
target country and make contact and establish a customer relationship with indi-
vidual hospitals (Nelde 2020).  
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FIGURE 15. Recommended implementation process 
 
Regarding the current state of emergency due to COVID-19 (Corona Virus Dis-
ease 2019), all hospitals are in many ways at their limit. Right now, they are only 
making the most essential investments and it is expected that even after the crisis 
has leveled off, many health facilities will remain with financial damage. Against 
this background, no concrete recommendation about the timing of the market 
entry can be made, other than the obvious, which is to wait and see how the 
situation develops. In the long-term, the epidemy could promote the digitization 
of German hospitals and thus create a favorable starting point for Company X to 
introduce its service. 
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A similar process could be applied if the commissioning company decided to ex-
pand its business operations even further to new markets or new countries. Same 
as in this study, the process should start with a thorough market analysis to de-
termine the size of the market, the legal framework, the behavior of the potential 
customers and their demand for the product or service, the strength of the com-
petition, and potential distributor or partners. The results will enable the company 
to evaluate its strengths and weaknesses and possible challenges and opportu-
nities that exist in the new target market. 
 
If the results of the market analysis match the needs and goals of the company, 
or in other words, if the new market is found to be suitable, an entry strategy 
should be specified. This should include the entry mode, the objectives to be 
achieved, how the company plans to position itself in the new market, which cus-
tomer groups to target and how to communicate with them, as well as a selection 
of the distributors and partners. Furthermore, the timing for the market entry 
should be scheduled, the price for the product or service determined, and a place 
chosen where the offering will be made available to the customers.  
 
Finally, it will be possible to implement the entry strategy and launch the business 
operations to the new market. In the course of the implementation representatives 
of the company could attend events and trade fairs in the target market to intro-
duce the company and its services, and initiate pilot projects. After the launch it 
will be crucial to measure the performance, follow-up, and review the work of the 
distributors and partners and adjust the operations accordingly. If the market en-
try has been accomplished successfully, the business operations can be further 
expanded to serve the entire market.  
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FIGURE 16. Market entry process 
 
 
5.2 Limitations of the research 
 
This research aims to investigate the German hospital market and gain insights 
into the routines and challenges of medical staff and managers. However, the 
findings have to be seen in the light of some limitations. While planning the data 
collection, it was expected to reach several representatives of different profes-
sional groups within the healthcare sector to collect their insights and opinions. 
Unfortunately, the data collection process was seriously disrupted by the rapid 
spread of the COVID-19 virus. Therefore, only exemplary opinions and experi-
ences of nursing staff could be obtained. Due to the low sample size, the results 
cannot be generalized and serve only as an exemplary presentation of the chal-
lenges of German hospitals and their expectations about digital solutions. In order 
to increase the knowledge about experiences, thoughts, and opinions of medical 
professionals, it is therefore recommended to conduct further surveys or inter-
views at a later time, when the situation has stabilized.  
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Another limitation occurred during the search for potential distributors for digital 
devices. Since digital solutions are not yet implemented extensively across the 
German hospital landscape, the number of distributors specializing in the fields 
of mobile devices and IT services for healthcare is very low. Most distributors are 
specialized in hospital software and systems and digital devices are only a sub-
category in the product lines. Nonetheless, as the results of this study show, trade 
fairs and congresses are great possibilities to meet potential distributors and part-
ners and should, therefore, be considered as a way to overcome this limitation. 
 
 
5.3 Opportunities for further research 
 
Given the anticipated scope and time of a bachelor’s thesis, this research focuses 
solely on the German hospital sector. However, during the data collection pro-
cess, it was noted that there is also a growing need for elderly care in Germany. 
It is expected that people above 67 will make up one-fourth of the entire popula-
tion in the close future. From 2007 to 2017 the number of nursing homes in Ger-
many raised from 11,000 to 14,500 and already now 3.4 million people are in 
need of long-term care (Statistisches Bundesamt 2019). The comfort and func-
tionality of nursing homes play an essential role in making everyday life as pleas-
ant and worth living as possible for both residents and nursing staff. The service 
of Company X could enhance everyday care at German elderly care homes by 
entertaining their residents and thereby increasing their living comfort. 
 
It would also be interesting to investigate more about the need for this kind of 
service in private practices of self-employed healthcare professionals. The Fed-
eral Health Reporting counted over 100,000 medical practices in Germany in 
2019 (Gesundheitsberichterstattung des Bundes 2020). The service of Company 
X could contribute to the entertainment of patients in the waiting rooms and sup-
port staff in their daily tasks, for example in data entry or explaining conditions 
and treatments to patients.  
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APPENDICES  
Appendix 1. The top 30 university hospitals in Germany 
 
TABLE 1. Extract from the Top 100 Clinics (Niehaus 2019)  
Nr. Clinic name Federal State 1 Charité - Universitätsklinikum Berlin Berlin 2 Universitätsklinikum Carl Gustav Carus Saxony 3 Universitätsklinikum Heidelberg Baden-Württemberg 4 Klinikum der Universität München Bavaria 5 Universitätsklinikum Tübingen Baden-Württemberg 6 Universitätsklinikum Leipzig Saxony 7 Universitätsklinikum Frankfurt Hesse 8 Universitätsklinikum Köln North Rhine-Westphalia 9 Universitätsklinikum Bonn North Rhine-Westphalia 10 Universitätsklinikum Würzburg Bavaria 11 Universitätsklinikum Jena Saxony 12 Universitätsklinikum Freiburg Baden-Württemberg 13 Klinikum r. d. Isar der TU München Bavaria 14 Universitätsklinikum Hamburg-Eppendorf Hamburg 15 Universitätsklinikum Erlangen Bavaria 16 Medizinische Hochschule Hannover Lower Saxony 17 Universitätsmedizin Mainz Rhineland Pfalz 18 Universitätsklinikum Düsseldorf North Rhine-Westphalia 19 Universitätsklinikum Essen North Rhine-Westphalia 20 Universitätsklinikum Gießen und Marburg Hesse 21 Universitätsklinikum Ulm Baden-Württemberg 22 Uniklinik RWTH Aachen North Rhine-Westphalia 23 Universitätsklinikum Augsburg Bavaria 24 Universitätsklinikum Münster North Rhine-Westphalia 25 Universitätsklinikum SH, Campus Kiel Schleswig-Holstein 26 Universitätsmedizin Mannheim Baden-Württemberg 27 Universitätsmedizin Göttingen Lower Saxony 28 Klinikum Stuttgart Baden-Württemberg 29 Klinikum Nürnberg Bavaria 30 Universitätsklinikum SH, Campus Lübeck Schleswig-Holstein  
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Appendix 2. The top 9 private clinics in Germany 
 
TABLE 2. Germany’s top 9 private clinics (praktischArzt 2020) 
 Nr. Clinic name Facilities in Germany Turnover (euro) 1 Helios Kliniken 216 6,000,000,000 2 Asklepios Kliniken 160 3,408,000,000 3 Sana Kliniken 59 2,703,000,000 4 Rhön Kliniken 5 1,233,000,000 5 Ameos Gruppe 80 843,000,000 6 Schön Klinik 17 835,000,000 7 Mediclin 36 645,000,000 8 SRH Kliniken 16 622,500,000 9 Paracelsus Kliniken 27 400,000,000 
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Appendix 3. Confidential 
Confidential information has been moved to a separate information sheet. 
